ARTICLE | Company News
MDS, Eli Lilly deal
January 20, 2003 8:00 AM UTC
MDS subsidiary MDS Proteomics partnered with Eli Lilly Canada Inc. (Toronto, Ontario) to research the use of MDS's PhosMap proteomics technology in LLY's kinase inhibitor program. ...